Is chronic inflammation a determinant of blood pressure in the elderly?

Michelangela Barbieri, Luigi Ferrucci, Anna Maria Corsi, Claudio Macchi, Fulvio Lauretani, Massimiliano Bonafè, Fabiola Olivieri, Simona Giovagnetti, Claudio Franceschi, Giuseppe Paolisso

Research output: Contribution to journalArticle

Abstract

Background: Previous studies have shown that a rise in blood pressure (BP) causes chronic inflammation of the endothelium which, in turn, may be responsible for further damage of endothelium and worsening of BP control. On the other hand, several metabolic abnormalities such as dyslipidemia, hyperinsulinemia/insulin-resistance, diabetes, and obesity causes inflammation followed by a later rise in arterial BP. We investigated the role of chronic inflammation in the modulation of BP independently of other traditional cardiovascular risk factors and atherosclerotic lesions. Methods: A total of 537 aged subjects, selected from the whole population of the INCHIANTI cohort, were enrolled. All subjects underwent plasma insulin, glucose, interleukin-6 (IL-6), interleukin- 10 (IL-10), interleukin-1β (IL-1β), interleukin-1 receptor antagonist (IL-1ra), C-reactive protein, and tumor necrosis factor-α (TNF-α levels determination. The IL-6-174 C/G promoter polymorphism was also evaluated. Results: After adjusting for age, sex, insulin resistance syndrome score, and severity of carotid atherosclerosis, serum IL-1β (P <.001), IL-1ra (P <.005) concentration and the insulin resistance syndrome score (P <.001) were the only predictors of diastolic BP. Indeed, age (P <.001), insulin resistance syndrome score (P = .05), IL-1β (P <.05), and severity of carotid atherosclerosis (P <.05) were the only significant predictor of systolic BP. Conclusion: These results suggest that chronic inflammation may play a role in the modulation of arterial BP.

Original languageEnglish (US)
Pages (from-to)537-543
Number of pages7
JournalAmerican Journal of Hypertension
Volume16
Issue number7
DOIs
StatePublished - Jul 1 2003
Externally publishedYes

Fingerprint

Blood Pressure
Inflammation
Interleukin-1
Insulin Resistance
Carotid Artery Diseases
Interleukin-1 Receptors
Endothelium
Interleukin-6
Arterial Pressure
Hyperinsulinism
Dyslipidemias
Interleukin-10
C-Reactive Protein
Tumor Necrosis Factor-alpha
Obesity
Insulin
Glucose
Serum
Population

Keywords

  • Atherosclerosis
  • Blood pressure
  • IL-1ra
  • IL-6 genotype
  • IL-6, IL-1β

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Barbieri, M., Ferrucci, L., Corsi, A. M., Macchi, C., Lauretani, F., Bonafè, M., ... Paolisso, G. (2003). Is chronic inflammation a determinant of blood pressure in the elderly? American Journal of Hypertension, 16(7), 537-543. https://doi.org/10.1016/S0895-7061(03)00861-6

Is chronic inflammation a determinant of blood pressure in the elderly? / Barbieri, Michelangela; Ferrucci, Luigi; Corsi, Anna Maria; Macchi, Claudio; Lauretani, Fulvio; Bonafè, Massimiliano; Olivieri, Fabiola; Giovagnetti, Simona; Franceschi, Claudio; Paolisso, Giuseppe.

In: American Journal of Hypertension, Vol. 16, No. 7, 01.07.2003, p. 537-543.

Research output: Contribution to journalArticle

Barbieri, M, Ferrucci, L, Corsi, AM, Macchi, C, Lauretani, F, Bonafè, M, Olivieri, F, Giovagnetti, S, Franceschi, C & Paolisso, G 2003, 'Is chronic inflammation a determinant of blood pressure in the elderly?', American Journal of Hypertension, vol. 16, no. 7, pp. 537-543. https://doi.org/10.1016/S0895-7061(03)00861-6
Barbieri M, Ferrucci L, Corsi AM, Macchi C, Lauretani F, Bonafè M et al. Is chronic inflammation a determinant of blood pressure in the elderly? American Journal of Hypertension. 2003 Jul 1;16(7):537-543. https://doi.org/10.1016/S0895-7061(03)00861-6
Barbieri, Michelangela ; Ferrucci, Luigi ; Corsi, Anna Maria ; Macchi, Claudio ; Lauretani, Fulvio ; Bonafè, Massimiliano ; Olivieri, Fabiola ; Giovagnetti, Simona ; Franceschi, Claudio ; Paolisso, Giuseppe. / Is chronic inflammation a determinant of blood pressure in the elderly?. In: American Journal of Hypertension. 2003 ; Vol. 16, No. 7. pp. 537-543.
@article{417e753e15004081b0baa67b82e64811,
title = "Is chronic inflammation a determinant of blood pressure in the elderly?",
abstract = "Background: Previous studies have shown that a rise in blood pressure (BP) causes chronic inflammation of the endothelium which, in turn, may be responsible for further damage of endothelium and worsening of BP control. On the other hand, several metabolic abnormalities such as dyslipidemia, hyperinsulinemia/insulin-resistance, diabetes, and obesity causes inflammation followed by a later rise in arterial BP. We investigated the role of chronic inflammation in the modulation of BP independently of other traditional cardiovascular risk factors and atherosclerotic lesions. Methods: A total of 537 aged subjects, selected from the whole population of the INCHIANTI cohort, were enrolled. All subjects underwent plasma insulin, glucose, interleukin-6 (IL-6), interleukin- 10 (IL-10), interleukin-1β (IL-1β), interleukin-1 receptor antagonist (IL-1ra), C-reactive protein, and tumor necrosis factor-α (TNF-α levels determination. The IL-6-174 C/G promoter polymorphism was also evaluated. Results: After adjusting for age, sex, insulin resistance syndrome score, and severity of carotid atherosclerosis, serum IL-1β (P <.001), IL-1ra (P <.005) concentration and the insulin resistance syndrome score (P <.001) were the only predictors of diastolic BP. Indeed, age (P <.001), insulin resistance syndrome score (P = .05), IL-1β (P <.05), and severity of carotid atherosclerosis (P <.05) were the only significant predictor of systolic BP. Conclusion: These results suggest that chronic inflammation may play a role in the modulation of arterial BP.",
keywords = "Atherosclerosis, Blood pressure, IL-1ra, IL-6 genotype, IL-6, IL-1β",
author = "Michelangela Barbieri and Luigi Ferrucci and Corsi, {Anna Maria} and Claudio Macchi and Fulvio Lauretani and Massimiliano Bonaf{\`e} and Fabiola Olivieri and Simona Giovagnetti and Claudio Franceschi and Giuseppe Paolisso",
year = "2003",
month = "7",
day = "1",
doi = "10.1016/S0895-7061(03)00861-6",
language = "English (US)",
volume = "16",
pages = "537--543",
journal = "Journal of clinical hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Is chronic inflammation a determinant of blood pressure in the elderly?

AU - Barbieri, Michelangela

AU - Ferrucci, Luigi

AU - Corsi, Anna Maria

AU - Macchi, Claudio

AU - Lauretani, Fulvio

AU - Bonafè, Massimiliano

AU - Olivieri, Fabiola

AU - Giovagnetti, Simona

AU - Franceschi, Claudio

AU - Paolisso, Giuseppe

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Background: Previous studies have shown that a rise in blood pressure (BP) causes chronic inflammation of the endothelium which, in turn, may be responsible for further damage of endothelium and worsening of BP control. On the other hand, several metabolic abnormalities such as dyslipidemia, hyperinsulinemia/insulin-resistance, diabetes, and obesity causes inflammation followed by a later rise in arterial BP. We investigated the role of chronic inflammation in the modulation of BP independently of other traditional cardiovascular risk factors and atherosclerotic lesions. Methods: A total of 537 aged subjects, selected from the whole population of the INCHIANTI cohort, were enrolled. All subjects underwent plasma insulin, glucose, interleukin-6 (IL-6), interleukin- 10 (IL-10), interleukin-1β (IL-1β), interleukin-1 receptor antagonist (IL-1ra), C-reactive protein, and tumor necrosis factor-α (TNF-α levels determination. The IL-6-174 C/G promoter polymorphism was also evaluated. Results: After adjusting for age, sex, insulin resistance syndrome score, and severity of carotid atherosclerosis, serum IL-1β (P <.001), IL-1ra (P <.005) concentration and the insulin resistance syndrome score (P <.001) were the only predictors of diastolic BP. Indeed, age (P <.001), insulin resistance syndrome score (P = .05), IL-1β (P <.05), and severity of carotid atherosclerosis (P <.05) were the only significant predictor of systolic BP. Conclusion: These results suggest that chronic inflammation may play a role in the modulation of arterial BP.

AB - Background: Previous studies have shown that a rise in blood pressure (BP) causes chronic inflammation of the endothelium which, in turn, may be responsible for further damage of endothelium and worsening of BP control. On the other hand, several metabolic abnormalities such as dyslipidemia, hyperinsulinemia/insulin-resistance, diabetes, and obesity causes inflammation followed by a later rise in arterial BP. We investigated the role of chronic inflammation in the modulation of BP independently of other traditional cardiovascular risk factors and atherosclerotic lesions. Methods: A total of 537 aged subjects, selected from the whole population of the INCHIANTI cohort, were enrolled. All subjects underwent plasma insulin, glucose, interleukin-6 (IL-6), interleukin- 10 (IL-10), interleukin-1β (IL-1β), interleukin-1 receptor antagonist (IL-1ra), C-reactive protein, and tumor necrosis factor-α (TNF-α levels determination. The IL-6-174 C/G promoter polymorphism was also evaluated. Results: After adjusting for age, sex, insulin resistance syndrome score, and severity of carotid atherosclerosis, serum IL-1β (P <.001), IL-1ra (P <.005) concentration and the insulin resistance syndrome score (P <.001) were the only predictors of diastolic BP. Indeed, age (P <.001), insulin resistance syndrome score (P = .05), IL-1β (P <.05), and severity of carotid atherosclerosis (P <.05) were the only significant predictor of systolic BP. Conclusion: These results suggest that chronic inflammation may play a role in the modulation of arterial BP.

KW - Atherosclerosis

KW - Blood pressure

KW - IL-1ra

KW - IL-6 genotype

KW - IL-6, IL-1β

UR - http://www.scopus.com/inward/record.url?scp=0038235867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038235867&partnerID=8YFLogxK

U2 - 10.1016/S0895-7061(03)00861-6

DO - 10.1016/S0895-7061(03)00861-6

M3 - Article

VL - 16

SP - 537

EP - 543

JO - Journal of clinical hypertension

JF - Journal of clinical hypertension

SN - 0895-7061

IS - 7

ER -